ATyr Pharma Analyst Ratings
BenzingaMar 16 00:47
RBC Capital Maintains Outperform on ATyr Pharma, Lowers Price Target to $16
BenzingaMar 16 00:49
Analysts Offer Insights on Healthcare Companies: ATyr Pharma (LIFE), Conmed (CNMD) and Ascendis Pharma (ASND)
TipRanksMar 15 18:50
Buy Rating Affirmed for ATyr Pharma as Lead Candidate Efzofitimod Advances in Clinical Trials With Solid Financial Footing
TipRanksMar 15 18:25
ATyr Pharma Analyst Ratings
BenzingaMar 15 18:18
ATyr Pharma Analyst Ratings
BenzingaFeb 22 00:14
Analysts Offer Insights on Healthcare Companies: ATyr Pharma (LIFE), CVS Health (CVS) and Science 37 (SNCE)
TipRanksFeb 9 21:50
ATyr Pharma (LIFE) Gets a Hold From Oppenheimer
TipRanksNov 22, 2023 20:55
Promising Potential of ATyr Pharma's Efzofitimod in Treating Rheumatoid Arthritis and Associated Lung Disease Underpins Buy Rating
TipRanksNov 14, 2023 19:26
RBC Capital Keeps Their Buy Rating on ATyr Pharma (LIFE)
TipRanksNov 11, 2023 09:48
ATyr Pharma (LIFE) Receives a Buy From Piper Sandler
TipRanksNov 10, 2023 23:16
Robust Financial Health and Promising Clinical Progress Prompt 'Buy' Rating for ATyr Pharma
TipRanksNov 10, 2023 19:46
Promising Developments in ATyr Pharma's Efzofitimod Clinical Trials Lead to Buy Rating
TipRanksOct 31, 2023 22:06
Analysts Offer Insights on Healthcare Companies: ATyr Pharma (LIFE) and Pfizer (PFE)
TipRanksOct 31, 2023 22:01
Piper Sandler Sticks to Its Buy Rating for ATyr Pharma (LIFE)
TipRanksOct 4, 2023 18:56
Buy Rating for ATyr Pharma: Promising Developments in Efzofitimod Clinical Trials and Potential Expansion Opportunities
TipRanksSep 26, 2023 22:25
ATyr Pharma (LIFE) Gets a Buy From Piper Sandler
TipRanksSep 26, 2023 18:35
Analysts Offer Insights on Healthcare Companies: ATyr Pharma (LIFE), Genfit SA (GNFT) and Boston Scientific (BSX)
TipRanksSep 21, 2023 18:32
HC Wainwright & Co. Reiterates Buy on ATyr Pharma, Maintains $35 Price Target
BenzingaSep 21, 2023 18:22
ATyr Pharma Analyst Ratings
BenzingaSep 21, 2023 18:22
No Data
No Data